Full Press Release Details
SOUTH SAN FRANCISCO, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, today announced management will present at the following investor conferences this month:
Jefferies London Healthcare Conference: Fireside chat on Wednesday, November 15 at 5:00 p.m. GMT
Evercore ISI HealthCONx Conference: Fireside chat on Wednesday, November 29 at 7:30 a.m. ET
Live webcasts of the Company presentations will be available through the investor relations section of the Company's website at www.akerotx.com. Following the live webcasts, archived replays will be available on the Company's website.
About Akero Therapeutics